GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹5,918 Cr | ₹5,218 Cr | ₹4,247 Cr | ₹6,172 Cr | ₹5,270 Cr |
What is the latest Net Current Assets ratio of GLAND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹5,918 Cr |
| Mar2025 | ₹5,218 Cr |
| Mar2024 | ₹4,247 Cr |
| Mar2023 | ₹6,172 Cr |
| Mar2022 | ₹5,270 Cr |
How is Net Current Assets of GLAND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,918 Cr | 13.42 | |
| Mar2025 | ₹5,218 Cr | 22.87 | |
| Mar2024 | ₹4,247 Cr | -31.19 | |
| Mar2023 | ₹6,172 Cr | 17.11 | |
| Mar2022 | ₹5,270 Cr | - | |
Compare Net Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹54,967.3 Cr | -1.4% | 16.5% | 81.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.4% |
16.5% |
81.4% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses